Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Could toxicities due to cisplatin be ameliorated with the use of N-acetylcysteine? A randomized double-blind placebo-controlled trial

  • At: 2016 FIP Congress in Buenos Aires (Argentina)
  • Type: Poster
  • By: VISACRI, Marília (School of Medical Sciences (FCM), University of Campinas, Campinas, Brazil)
  • Co-author(s): Marília Berlofa Visacri:,School of Medical Sciences (FCM), University of Campinas,Campinas,Brazil|Júlia Quintanilha:,School of Medical Sciences (FCM), University of Campinas,Campinas,Brazil|Vanessa Sousa:,Faculty of Pharmaceutical Sciences (FCF), University of Campinas,Campinas,Brazil|Gabriela De Vito:,Faculty of Pharmaceutical Sciences (FCF), University of Campinas,Campinas,Brazil|Rosiane Ambrósio:,School of Medical Sciences (FCM), University of Campinas,Campinas,Brazil|Luciane Calonga:,Clinical Hospital, University of Campinas,Campinas,Brazil|Silvia Curi:,Clinical Hospital, University of Campinas,Campinas,Brazil|Carlos Chone:,Clinical Hospital, University of Campinas,Campinas,Brazil|Carmen Lima:,School of Medical Sciences (FCM), University of Campinas,Campinas,Brazil|Patricia Moriel:,Faculty of Pharmaceutical Sciences (FCF), University of Campinas,Campinas,Brazil
  • Abstract:

    Cisplatin chemotherapy induces oxidative stress and therefore has consequent toxicities. The protective antioxidant role of N-acetylcysteine (NAC) on toxicity due to cisplatin has been reported in experimental models; however, its efficacy in patients has not been elucidated. 

    A pilot study was conducted with 12 patients undergoing treatment with

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses